title: New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
authors.affiliation: Johns Hopkins Oncology Center, Johns Hopkins School of Medicine, Baltimore, Md.
authors.forename: W B
authors.initials: WB
authors.lastname: Isaacs
authors.forename: J T
authors.initials: JT
authors.lastname: Isaacs
authors.forename: N
authors.initials: N
authors.lastname: Kyprianou
authors.forename: J K
authors.initials: JK
authors.lastname: Burgers
authors.forename: R B
authors.initials: RB
authors.lastname: Alexander
authors.forename: A W
authors.initials: AW
authors.lastname: Partin
authors.forename: J L
authors.initials: JL
authors.lastname: Mohler
authors.forename: F F
authors.initials: FF
authors.lastname: Marshall
authors.forename: D S
authors.initials: DS
authors.lastname: Coffey
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D002465:Cell Movement / Q000502:physiology; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
chemical_list: D014409:Tumor Necrosis Factor-alpha; D005047:Etoposide